Neonatal encephalopathies are central nervous system disorders that are often accompanied by seizures. Seizures are one of the distinctive clinical manifestations of epilepsy, hypoxia, abnormal delivery, sleep deprivation and stress. Magnetic Resonance Imaging (MRI) plays a crucial role in the diagnosis and understanding of neonatal seizures. However, neonatal MRI evaluation is incomplete in assessing the entire neonate?s neurologic status, especially in regards to cortical functioning. In such circumstances, continuous video EEG can be useful as it provides important information about changes in frequency, synchrony, distribution and other characteristics of cerebral cortical activity. EEG is also a key modality in the understanding of developmental disabilities from early childhood. State-of-the-art EEG or dense array EEG (HD-EEG ? 64 or more channels) has enabled the realization of EEG?s potential as a neuroimaging tool through source localization of normal and pathological brain activity and network dynamics. However, neither conventional EEG nor HD-EEG are imaging (MRI or CT) compatible; hence, EEG electrodes are typically removed prior to any imaging study, with negative impacts on patient management because of extra delays and additional costs. The goal of this R01 project is to demonstrate the feasibility and safety of developing an imaging-compatible HD-EEG net for cross-modal neonatal neural monitoring with artifact-free image quality. The proposed neonatal HD-EEG net or ?NeoNet? will be designed by leveraging expertise in innovative 3D printing technology and thin film deposition at the A. A. Martinos Center, Massachusetts General Hospital. Rigorous safety assessment of specific absorption deposition rate and temperature will be performed using Finite Elements Method (FEM) simulations employing anatomically accurate male and female 2-week-old neonatal whole body models, which will be released to the public. Simulations will be validated by actual temperature measurements of induced RF heating using neonate phantoms wearing the NeoNet and compared against the gold standard of the phantom alone and against a commercial MR-compatible net built with traditional copper wire technology. Similarly, MRI data quality will be compared to data from the phantom-alone gold standard, and against data from the commercial HD-EEG. CT data integrity will also be evaluated. The proposed NeoNet will enable inexpensive, noninvasive HD-EEG and overcome current cross-modal safety and artifact issues that have so far severely limited the effectiveness of simultaneous HD-EEG/MRI allowing researchers and clinicians to benefit from the high spatial resolution of MRI and the high temporal resolution of HD-EEG. Furthermore, the technology will be light weight and small in size, taking advantage of advanced manufacturing technologies. The novel NeoNet will allow the study of brain function in healthy neonates in natural settings, as well as the understanding of different neonatal neural pathologies, such as epilepsy.

Public Health Relevance

The goal of this R01 project is to demonstrate the feasibility and safety of developing a dense array, image-compatible, neonatal EEG net ?NeoNet? (HD-EEG) using novel conductive Thin Film technologies. The proposed infant NeoNet will provide safe, noninvasive and affordable HD-EEG/MRI technology to both clinicians and researchers, thereby enabling routine multimodal imaging of human brain function with unprecedented spatiotemporal resolution in the neonatal period. The important innovations of the grant are: (a) the development and free distribution of novel, newborn body models - our adult head models have been used both internally at MGH and by outside companies like Siemens for safety studies of commercial MRI coils, (b) state-of-the-art safety electromagnetic modeling of newborns with EEG/fMRI, (c) development of a novel 3D printing technology for fabrication of MRI/CT transparent nets, and once the nets are built and tested, (d) the translation of this imaging-compatible EEG net technology into the clinics at Boston Children?s Hospital.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
3R01EB024343-03S1
Application #
10001797
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Wang, Shumin
Project Start
2017-09-15
Project End
2021-05-31
Budget Start
2019-09-15
Budget End
2020-05-31
Support Year
3
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114